PolarityBio to Present Phase 3 SkinTE Data at SAWC Fall 2026
SALT LAKE CITY — September 29, 2026 PolarityBio announced that results from its pivotal Phase 3 COVER DFUS II...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
SALT LAKE CITY — September 29, 2026 PolarityBio announced that results from its pivotal Phase 3 COVER DFUS II...
San Diego, California, U.S., September 24, 2026 Lakewood-Amedex Biotherapeutics has announced that the first patient has been dosed in...
SCOTTSDALE, Ariz. — September 22, 2026 Applied Biologics announced Last Patient, Last Visit (LPLV) in the 222-patient CAMPX multicenter...
August 24, 2026 | New Brunswick, New Jersey Johnson & Johnson announced the publication of the DISH Classification System,...
VALENCIA, Calif., August 18, 2026 AVITA Medical, Inc. announced positive results from the multicenter, randomized controlled PermeaDerm-I clinical study,...
Phoenix, Arizona, August 3, 2026 BioLab Holdings, Inc. has announced the publication of a peer-reviewed real-world evidence (RWE) study...
CANTON, Mass., July 27, 2026 Organogenesis Holdings Inc. announced the publication of peer-reviewed clinical trial results demonstrating the effectiveness...
DALLAS, July 8, 2026 Spectral AI, Inc. announced the appointment of Darcy Bajko as Chief Commercial Officer, effective July...
MISSISSAUGA, Ontario, April 15, 2026 Covalon Technologies Ltd. has reported a series of significant milestones across vascular access, infection...
Conshohocken, PA, November 28, 2025 Tiger BioSciences has spotlighted new scientific findings from a peer-reviewed study comparing 2-, 3-,...
